title: Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice.
abstract: Diabetes is associated with higher incidence of myocardial infarction (MI) and increased propensity for subsequent events post-MI. Here we conducted a temporal analysis of the influence of diabetes on cardiac dysfunction and remodeling after ischemia reperfusion (IR) injury in mice. Diabetes was induced using streptozotocin and IR performed by ligating the left anterior descending coronary artery for 30 min followed by reperfusion for up to 42 days. We first evaluated changes in cardiac function using echocardiography after 24 hours reperfusion and observed IR injury significantly decreased the systolic function, such as ejection fraction, fractional shortening and end systolic left ventricular volume (LVESV) in both control and diabetic mice. The longitudinal systolic and diastolic strain rate were altered after IR, but there were no significant differences between diabetic mice and controls. However, a reduced ability to metabolize glucose was observed in the diabetic animals as determined by PET-CT scanning using 2-deoxy-2-((18)F)fluoro-D-glucose. Interestingly, after 24 hours reperfusion diabetic mice showed a reduced infarct size and less apoptosis indicated by TUNEL analysis in heart sections. This may be explained by increased levels of autophagy detected in diabetic mice hearts. Similar increases in IR-induced macrophage infiltration detected by CD68 staining indicated no change in inflammation between control and diabetic mice. Over time, control mice subjected to IR developed mild left ventricular dilation whereas diabetic mice exhibited a decrease in both end diastolic left ventricular volume and LVESV with a decreased intraventricular space and thicker left ventricular wall, indicating concentric hypertrophy. This was associated with marked increases in fibrosis, indicted by Masson trichrome staining, of heart sections in diabetic IR group. In summary, we demonstrate that diabetes principally influences distinct IR-induced chronic changes in cardiac function and remodeling, while a smaller infarct size and elevated levels of autophagy with similar cardiac function are observed in acute phase.
authors.affiliation: Institut Pasteur Korea, Seoul, South Korea.
authors.forename: Megumi
authors.initials: M
authors.lastname: Eguchi
authors.forename: Young Hwa
authors.initials: YH
authors.lastname: Kim
authors.forename: Keon Wook
authors.initials: KW
authors.lastname: Kang
authors.forename: Chi Young
authors.initials: CY
authors.lastname: Shim
authors.forename: Yangsoo
authors.initials: Y
authors.lastname: Jang
authors.forename: Thierry
authors.initials: T
authors.lastname: Dorval
authors.forename: Kwang Joon
authors.initials: KJ
authors.lastname: Kim
authors.forename: Gary
authors.initials: G
authors.lastname: Sweeney
mesh_terms: D000818:Animals; D001343:Autophagy; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D004562:Electrocardiography; D005947:Glucose / Q000378:metabolism; D051379:Mice; D009203:Myocardial Infarction / Q000150:complications* / Q000473:pathology; D015428:Myocardial Reperfusion Injury / Q000150:complications*; D013599:Systole; D018487:Ventricular Dysfunction, Left; D020257:Ventricular Remodeling
chemical_list: D005947:Glucose